Form 4/A for ENVA Enova International, Inc.
Accepted 2023-12-14 00:00:00 ET · period of report 2023-02-13 · accession 0000950170-23-070534 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-12-14 | 2023-02-13 | ENVA | Cunningham Steven E | CFO | F - Tax | $50.21 | -3,377 | 189.0K | -2% | -$169.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 | 2023-02-13 | F | D | 3,377 | $50.21 | 188,953 | D | — | — | (F1) Includes timed-based restricted stock units previously granted to the Reporting Person. (F2) The original Form 4, filed February 15, 2023, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the sale of 3,577 shares for the payment of tax liability issued in accordance with Rule 16b-3, when the correct reported sale of shares should have been 3,377 shares. As a result of the administrative error, the total number of securities beneficially owned following the transaction should be reported as 188,953 instead of the previously reported 188,753. (F3) The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. |